JNJ is Johnson & Johnson (Healthcare). Trading at $234.34. Current dividend yield: 2.29%.
Dividend snapshot
| Annual dividend rate | $5.36 |
| Current yield | 2.29% |
| Payment frequency | Quarterly |
| Next ex-dividend date | May 26, 2026 |
| Most recent payment date | Mar 10, 2026 |
| Last payment amount | $1.3000 |
| 5-year dividend CAGR | 5.25% |
| 3-year dividend CAGR | 4.92% |
| Payout ratio | 60% |
| Market cap | $564.11B |
| Exchange | NYQ |
Recent dividend payments
| Date | Amount / share |
|---|---|
| 2026-02-24 | $1.3000 |
| 2025-11-25 | $1.3000 |
| 2025-08-26 | $1.3000 |
| 2025-05-27 | $1.3000 |
| 2025-02-18 | $1.2400 |
| 2024-11-26 | $1.2400 |
| 2024-08-27 | $1.2400 |
About JNJ
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Track JNJ in DiviDrip
Add JNJ to your portfolio on DiviDrip to track every buy, DRIP reinvestment, and dividend payment in one place. Free, no credit card, no upsell — built by dividend investors, for dividend investors.
- Open DiviDrip — search JNJ and add your shares.
- View the JNJ Dividend Triangle — see Revenue × EPS × Dividend growth at a glance.
- Stock Screener — find more dividend payers like JNJ.
- DiviDrip Learn — free guides on DRIP, dividend tiers, ETF comparisons.
Data refreshed 2026-05-24. Not investment advice. Yields and prices change continuously; always verify the latest numbers in the live app before buying.